For most people with treatment-resistant depression, TMS is worth serious consideration. About half of patients see meaningful improvement, and roughly a third achieve full remission, which is a strong result given that these are people whose depression hasn’t responded to medication. But “worth it” depends on your specific situation: how severe your depression is, what you’ve already tried, whether insurance will cover it, and how much time you can commit to treatment.
What TMS Actually Does to Your Brain
Transcranial magnetic stimulation uses magnetic pulses delivered through a coil placed against your scalp. These pulses generate small electrical currents in the outer layer of your brain, activating nerve cells in a targeted region. For depression, that target is typically the left prefrontal cortex, an area involved in mood regulation that tends to be underactive in people with depression.
High-frequency stimulation (above 5 Hz) increases activity in the targeted area, while low-frequency stimulation (below 1 Hz) dampens it. Most depression protocols use high-frequency pulses on the left side, low-frequency on the right side, or both. Over the course of treatment, these repeated sessions appear to reshape how brain cells communicate with each other, strengthening connections that have weakened during prolonged depression. The treatment also increases levels of key brain chemicals involved in mood, including serotonin and dopamine activity in the prefrontal cortex.
How Effective TMS Is by the Numbers
Response rates for TMS in major depression fall between 50% and 55%. “Response” means a substantial reduction in symptoms, typically at least a 50% improvement. Full remission, where symptoms resolve almost entirely, occurs in 30% to 35% of patients. These numbers come from people with treatment-resistant depression, meaning they’d already tried antidepressants without adequate relief. For a population that has failed other treatments, a one-in-three shot at remission is significant.
To put this in context, a head-to-head comparison with electroconvulsive therapy (ECT) found that ECT achieved a 53% remission rate compared to about 32% for high-frequency TMS. ECT remains the more powerful treatment for severe, refractory depression. But TMS doesn’t require anesthesia, doesn’t carry the risk of memory problems that ECT does, and is far better tolerated overall. For many patients, TMS hits a practical sweet spot between medication (which they’ve already failed) and ECT (which is more invasive).
How Long Results Last
A large naturalistic study tracked 120 patients who responded to an initial course of TMS over one year. Of those, 62.5% maintained their improvement throughout the follow-up period. The proportion who achieved remission at the end of acute treatment remained similar at the one-year mark, suggesting that for the majority of responders, the benefits hold.
That said, the risk of relapse is real, particularly around five months after treatment ends. Some clinicians offer maintenance sessions to reduce this risk, though the evidence on optimal maintenance schedules is still developing. Research suggests that very infrequent sessions (two or fewer per month) aren’t enough to prevent relapse in most people. If you do respond well to an initial course, having a plan for what happens next is important.
The Time Commitment
A standard course of TMS involves at least 30 sessions. With traditional protocols, that means daily weekday treatments over six to eight weeks. Each session lasts roughly 20 to 40 minutes depending on the protocol. Newer approaches, including intermittent theta burst stimulation, can shorten individual sessions to just a few minutes and compress the overall timeline. Some accelerated protocols deliver multiple sessions per day and complete the entire course in about one week.
For most people, the six-to-eight-week daily schedule is the biggest practical hurdle. You’ll need to arrange your work and personal life around near-daily appointments for close to two months. There’s no sedation, no recovery time after each session, and you can drive yourself home and return to normal activities immediately.
What It Costs
A single TMS session ranges from $700 to nearly $2,000, putting a full course of treatment at around $25,000 before insurance. Some clinics offer self-pay discounts that bring the total closer to $15,000. With insurance coverage, you’ll typically pay a copay per session plus any applicable deductible, which can make the cost manageable.
Most insurers now cover TMS, but they impose specific criteria. You generally need to be over 18, have a diagnosis of depression, and demonstrate that multiple antidepressant trials have failed. Some plans only cover one course of treatment, so it’s worth confirming the details with your insurer before starting. TMS is also FDA-cleared for OCD, migraines, smoking cessation, and depression with comorbid anxiety, though insurance coverage for these indications can be harder to secure.
Side Effects and Safety
TMS has a mild side effect profile compared to most depression treatments. The most common complaint is scalp discomfort or a tapping sensation at the coil site during treatment, which usually diminishes over the first few sessions. Headaches after treatment are also common early on but tend to resolve quickly.
The most serious potential risk is seizure, and the numbers are reassuring. A review of over 318,000 TMS sessions identified 24 seizures, putting the rate at roughly 1 in 13,000 sessions. When treatment follows published safety guidelines and patients don’t have additional risk factors, the rate drops to fewer than 1 seizure per 60,000 sessions. There is no general anesthesia, no systemic drug side effects, and no cognitive impairment.
Who Shouldn’t Get TMS
Certain conditions rule out TMS entirely. Non-removable metal in or near the head (excluding dental hardware) is the primary contraindication, since the magnetic field can heat or move conductive or ferromagnetic material. Any implanted device controlled by physiological signals is also disqualifying, including deep brain stimulators and cochlear implants. Wearable cardioverter-defibrillators are another absolute contraindication.
Relative contraindications include pregnancy, cardiac pacemakers, heart disease, and medications known to lower the seizure threshold such as certain older antidepressants and antipsychotics. These don’t automatically disqualify you, but they require careful risk-benefit discussion. Use in children and adolescents remains off-label.
Who Gets the Most Out of TMS
TMS works best as a next step for people whose depression hasn’t responded to antidepressants but who aren’t yet at the severity level where ECT is clearly indicated. Research suggests the response may also depend on your specific depression subtype. Patients who still have the ability to experience pleasure from activities (preserved hedonic function) appear more likely to respond than those who have completely lost that capacity. This means TMS may be particularly well-suited for people with moderate treatment-resistant depression who still have some emotional range, even if their overall mood is severely impaired.
If you’ve tried two or more antidepressants without adequate relief, TMS offers a roughly 50/50 chance of meaningful improvement with minimal side effects and no systemic drug burden. For someone weighing months of continued medication trials against a structured six-week treatment with a clear endpoint, that tradeoff often tips in TMS’s favor. The cost and time commitment are real, but for the half of patients who respond, the results can be durable for a year or longer.